Pyridoxal Reprograms Peroxisomal Hydrogen Peroxide Metabolism to Induce Lethal Oxidative Stress in Ovarian Cancer
iMetaMed · 2026-03 · 2 (1)
DOI: 10.1002/imm3.70032 ↗Kurz gefasst
Fachartikel in der Zeitschrift iMetaMed, online erschienen am 15.03.2026. Verfasst von Ruonan Li und 12 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
While pyridoxal 5′‐phosphate (PLP) is considered the bioactive form of vitamin B6 with context‐dependent anticancer roles, we redefine its non‐phosphorylated precursor, pyridoxal (PL), as a direct and potent cytotoxic agent against ovarian cancer. Using validated patient‐derived organoids encompassing diverse histological subtypes and orthotopic in vivo models, we demonstrate that unmetabolized PL triggers lethal oxidative stress independent of PLP conversion. Mechanistically, PL induces PEX11A‐dependent peroxisome fission and disrupts PEX5‐dependent catalase import, fundamentally switching peroxisomal function from a protective hydrogen peroxide (H 2 O 2 ) scavenger to a dominant H 2 O 2 generator through accelerated fatty acid β‐oxidation. This peroxisome‐driven H 2 O 2 surge propagates severe oxidative damage, causing mitochondrial dysfunction, DNA fragmentation, and intrinsic apoptosis. The cytotoxic cascade is significantly rescued by antioxidants, confirming redox imbalance as the primary death mechanism. Our findings reveal an unprecedented mechanism wherein PL exploits peroxisomal metabolism to create a lethal H 2 O 2 overload, effectively repurposing a cellular detoxification organelle into a vulnerability. This work establishes unmodified PL as a novel cancer therapeutic agent by reprogramming redox homeostasis and positions peroxisomal H 2 O 2 flux as a druggable target in ovarian cancer. Inhibiting PL phosphorylation enhances efficacy, offering a promising strategy for targeting therapy‐resistant disease.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, R., Wang, H., Zhang, D., Gu, Q., Wang, J., Liu, B., Gao, H., Duan, J., Liu, Y., Huang, X., Bu, Y., He, T., & Linghu, H. (2026). Pyridoxal Reprograms Peroxisomal Hydrogen Peroxide Metabolism to Induce Lethal Oxidative Stress in Ovarian Cancer. iMetaMed, 2(1). https://doi.org/10.1002/imm3.70032
Vancouver
Li R, Wang H, Zhang D, Gu Q, Wang J, Liu B, et al. Pyridoxal Reprograms Peroxisomal Hydrogen Peroxide Metabolism to Induce Lethal Oxidative Stress in Ovarian Cancer. iMetaMed. 2026;2(1). doi:10.1002/imm3.70032
BibTeX
@article{Li2026,
author = {Li, Ruonan and Wang, Huiyan and Zhang, Dunke and Gu, Qiuying and Wang, Jinlong and Liu, Bin and Gao, Huabin and Duan, Jingya and Liu, Yimin and Huang, Xiaolan and Bu, Youquan and He, Tongchuan and Linghu, Hua},
title = {Pyridoxal Reprograms Peroxisomal Hydrogen Peroxide Metabolism to Induce Lethal Oxidative Stress in Ovarian Cancer},
journal = {iMetaMed},
year = {2026},
volume = {2},
number = {1},
doi = {10.1002/imm3.70032}
}
EUVIMED